CALIDI BIOTHERAPEUTICS INC (CLDI) Stock Analyst Ratings
NYSEARCA:CLDI - American Stock Exchange - US3207033099 - Common Stock
ChartMill assigns a Buy % Consensus number of 88% to CLDI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.38. This target is 734.42% above the current price.
CLDI was analyzed by 8 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about CLDI.
In the previous month the buy percentage consensus was at a similar level.
CLDI was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-06-27 | Ladenburg Thalmann | Initiate | Buy |
| 2024-05-15 | Baird | Maintains | Outperform -> Outperform |
| 2024-03-21 | Baird | Maintains | Outperform -> Outperform |
| 2024-03-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-22 | HC Wainwright & Co. | Initiate | Buy |
| 2023-10-09 | Baird | Initiate | Outperform |